Thus, this collectively underscores the intricate interplay between FA and inflammatory mediators, thereby elucidating the potential therapeutic and protection implications of FA in the management of conditions characterized by dysregulated hepcidin levels such as cancer, anemia and chronic inflammation. The gene discussed is HAMP; the disease is anemia.